Reporting of the presence of common interferences hemolysis (H), lipemia (L) and icterus (I) to physicians is crucial for the accurate interpretation of laboratory results.  Both the reporting of the interference as well as an interpretation of how the test result is affected is mandated by regulatory organizations (eg. QMPLS in Ontario).  Numerous chemistry analyzers on the market now offer applications to detect the degree of hemolysis, lipemia and icterus in clinical samples in an automated fashion.  Additionally, both instrument vendors’ technical bulletins and independently published literature is available to correlate the numerical values reported from the instrument to the degree of interference for each chemistry or immunoassay test.  Implementing a fully automated reporting  solution for HIL remains a challenge for many clinical laboratories.  

This session will review key considerations for designing a fully automated reporting system for HIL. 

At the end of this presentation participants will

1. describe approaches for standardizing the reporting process for common interferents hemolysis, icterus and lipemia
2. understand the benefits and limitations of automated HIL reporting
3. be aware of LIS considerations involved in automating HIL reporting